PARITY Reaches 50% of Enrollment Target
We are thrilled to announce that Michelle Ghert enrolled the 300th PARITY participant (and the 17th for Juravinski Hospital and Cancer Centre) this morning. This is a major milestone as it represents one-half of the total enrolment target for the trial. It is a very exciting time for the PARITY Investigators and the CEO as the hope of completing this study is now a reality. It’s time to celebrate!